N-methylene malonate of tetrahydroquinoline and derivatives thereof
申请人:Riker Laboratories, Inc.
公开号:US03969463A1
公开(公告)日:1976-07-13
Certain substituted 6,7-dihydro-1-oxo-1H,5H-benzo[ij]-quinolizine-2-carboxylic acids and hydrazides, esters, amides and salts thereof, intermediates therefor, and a process for their preparation are described; the compounds are active as anti-microbial agents.
Substituted benzo[ij]quinolinzine-2-carboxylic acids and derivatives
申请人:Riker Laboratories, Inc.
公开号:US03985882A1
公开(公告)日:1976-10-12
Certain substituted 6,7-dihydro-1-oxo-1H,5H-benzo[ij]-quinolizine-2-carboxylic acids and hydrazides, esters, amides and salts thereof, intermediates therefor, and a process for their preparation are described; the compounds are active as anti-microbial agents.
Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives
申请人:Riker Laboratories, Inc.
公开号:US04001243A1
公开(公告)日:1977-01-04
Certain substituted 6,7-dihydro-1-oxo-1H,5H-benzo[ij]-quinolizine-2-carboxylic acids and hydrazides, esters, amides and salts thereof, intermediates therefor, and a process for their preparation are described; the compounds are active as anti-microbial agents.
TETRAHYDROQUINOLINE COMPOSITIONS AS BET BROMODOMAIN INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:US20150232445A1
公开(公告)日:2015-08-20
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I:
wherein W, X, Y, Z, R
1
, R
2
, R
5
, and R
8
are as described herein.
TETRAHYDROQUINOLINE DERIVATIVES FOR USE AS BET INHIBITORS
申请人:Forma Therapeutics, Inc.
公开号:EP3799872A1
公开(公告)日:2021-04-07
The present invention relates to inhibitors of bromo and extra terminal (BET) bromodomains that are useful for the treatment of cancer, inflammatory diseases, diabetes, and obesity, having Formula I:
wherein W, X, Y, Z, R1, R2, R5, and R8 are as described herein.